Marine Polyhydroxynaphthoquinone, Echinochrome A: Prevention of Atherosclerotic Inflammation and Probable Molecular Targets

• Published in: Journal of clinical medicine 2020-05, Vol.9 (5), p.1494
• Main Authors: Artyukov, Aleksandr A, Zelepuga, Elena A, Bogdanovich, Larisa N, Lupach, Natalia M, Novikov, Vyacheslav L, Rutckova, Tatyana A, Kozlovskaya, Emma P
• Format: Article
• Language: English
• Subjects: Angina pectoris; Atherosclerosis; Biosynthesis; Calcification; Cardiac stress tests; Cardiovascular disease; Chronic illnesses; Clinical medicine; Clinical trials; Dietary supplements; Drugs; Electrocardiography; Laboratories; Lipids; Metabolism; Oxidative stress; Patients; Sample size; Therapy; Transcription factors; Tumor necrosis factor-TNF; Womens health
• ISSN: 2077-0383; 2077-0383
• DOI: 10.3390/jcm9051494

The effect of low doses of echinochrome A (EchA), a natural polyhydroxy-1,4-naphthoquinone pigment from the sea urchin , has been studied in clinical trials, when it was used as an active substance of the drug Histochrome and biologically active supplement Thymarin. Several parameters of lipid metabolism, antioxidant status, and the state of the immune system were analyzed in patients with cardiovascular diseases (CVD), including contaminating atherosclerosis. It has been shown that EchA effectively normalizes lipid metabolism, recovers antioxidant status and reduces atherosclerotic inflammation, regardless of the method of these preparations' administrations. Treatment of EchA has led to the stabilization of patients, improved function of the intracellular matrix and decreased epithelial dysfunction. The increased expression of surface human leukocyte antigen DR isotype (HLA-DR) receptors reflects the intensification of intercellular cooperation of immune cells, as well as an increase in the efficiency of processing and presentation of antigens, while the regulation of CD95 + expression levels suggests the stimulation of cell renewal processes. The immune system goes to a different level of functioning. Computer simulations suggest that EchA, with its aromatic structure of the naphthoquinone nucleus, may be a suitable ligand of the cytosolic aryl cell receptor, which affects the response of the immune system and causes the rapid expression of detoxification enzymes such as CYP and DT diaphorase, which play a protective role with CVD. Therefore, EchA possesses not only an antiradical effect and antioxidant activity, but is also a SOD3 mimetic, producing hydrogen peroxide and controlling the expression of cell enzymes through hypoxia-inducible factors (HIF), peroxisome proliferator-activated receptors (PPARs) and aryl hydrocarbon receptor (AhR).